Understanding Medication Adherence Among HIV Patients

Overview

In anticipation of a pilot study incorporating behavioral economics into the treatment of infectious diseases, we will conduct a survey with HIV/AIDS patients at the Ponce Clinic (Infectious Disease Program of Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA).

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 2011

Detailed Description

We are planning a study to improve health outcomes among patients with HIV/AIDS using insights from behavioral economics and financial incentives. We will conduct a survey with HIV/AIDS patients at Ponce Clinic (Infectious Disease Program of Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA). The patients will be low-income persons living with HIV/AIDS and possessing varying degrees of medication adherence. We want to better understand how this particular population would react to commitment devices designed to increase medication adherence. We will survey participants to see if they would prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment.

Interventions

  • Other: Survey to Understand Medication Adherence among HIV Patients
    • We want to better understand how this particular population would react to commitment devices designed to increase medication adherence. We will survey participants to see if they would prefer more commitment, in the form of a “Take-Medication-Get-Paid” plan; less commitment, in the form of an “Attend-Clinic-Get-Paid” plan; or if they would prefer to designate their own levels of commitment.

Arms, Groups and Cohorts

  • Other: Survey
    • We will survey participants to see if they would prefer more commitment, in the form of a “Take-Medication-Get-Paid” plan; less commitment, in the form of an “Attend-Clinic-Get-Paid” plan; or if they would prefer to designate their own levels of commitment.

Clinical Trial Outcome Measures

Primary Measures

  • Commitment Preferences for Increasing Medication Adherence
    • Time Frame: Up to 4 months
    • We will measure whether participants prefer more commitment, in the form of a “Take-Medication-Get-Paid” plan; less commitment, in the form of an “Attend-Clinic-Get-Paid” plan; or if they would prefer to designate their own levels of commitment.

Secondary Measures

  • Medication Adherence and Commitment Preference
    • Time Frame: Up to 4 months
    • We will measure how subjects’ medication adherence affects their stated commitment preferences.

Participating in This Clinical Trial

Inclusion Criteria

* HIV/AIDS patients currently receiving treatment at the Ponce Clinic at the Infectious Disease Program of Grady Memorial Hospital (Emory University School of Medicine).

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • National Bureau of Economic Research, Inc.
  • Collaborator
    • National Institute on Aging (NIA)
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • David I Laibson, Ph.D, Principal Investigator, National Bureau of Economic Research

Citations Reporting on Results

Alsan M, Beshears J, Armstrong WS, Choi JJ, Madrian BC, Nguyen MLT, Del Rio C, Laibson D, Marconi VC. A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS. AIDS. 2017 Jul 31;31(12):1765-1769. doi: 10.1097/QAD.0000000000001543.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.